2010
DOI: 10.1016/j.gastrohep.2009.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Lesión colestásica aguda por aceclofenaco

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…However, studies have shown that aceclofenac is biotransformed into chemically reactive metabolites capable of binding covalently to certain protein targets in the hepatocytes of animals administrated the drug [4], [5]. In addition, in vitro studies also revealed that the metabolic activation in hepatocytes produced 4-hydroxyaceclofenac and 5hydroxyaceclofenac which was mediated by UDPglucuronosyltransferase and cytochrome P450 isozymes (CYP1, CYP2B, CYP2C, CYP2C11 and CYP3A) [6,7], [8].…”
Section: Introductionmentioning
confidence: 99%
“…However, studies have shown that aceclofenac is biotransformed into chemically reactive metabolites capable of binding covalently to certain protein targets in the hepatocytes of animals administrated the drug [4], [5]. In addition, in vitro studies also revealed that the metabolic activation in hepatocytes produced 4-hydroxyaceclofenac and 5hydroxyaceclofenac which was mediated by UDPglucuronosyltransferase and cytochrome P450 isozymes (CYP1, CYP2B, CYP2C, CYP2C11 and CYP3A) [6,7], [8].…”
Section: Introductionmentioning
confidence: 99%